Sudden hearing loss associated with methylphenidate therapy. | Canada Hyperbarics Skip to main content
Clinical Study European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2014

Sudden hearing loss associated with methylphenidate therapy.

Karapinar U, Saglam O, Dursun E, Cetin B, Salman N, Sahan M — European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2014

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on an 8-year-old child who experienced sudden hearing loss, loss of balance, tinnitus, and ear fullness after starting methylphenidate therapy.

What They Found

They found that an 8-year-old patient developed total hearing loss in her left ear, along with loss of balance, tinnitus, and ear fullness, immediately after her first dose of methylphenidate. Despite receiving oral corticosteroids and hyperbaric oxygen therapy, the hearing loss remained irreversible.

Canadian Relevance

This study has no direct Canadian connection as it was conducted in another country.

Study Limitations

As a single case report, this study's findings cannot be generalized to the broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 24141471
Year Published 2014
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Central Nervous System Stimulants; Child; Female; Glucocorticoids; Hearing; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Methylphenidate; Prednisone

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology